Trial Profile
An oral, rising single-dose tolerance, pharmacokinetic, and pharmacodynamic study of Pf-00184562 capsules in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Mar 2009
Price :
$35
*
At a glance
- Drugs PF 184562 (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- 03 Oct 2006 New trial record.